Implant Sciences’ QS-B220 Desktop Explosives and Drugs Trace Detectors to be Showcased at Air Cargo Americas

Implant Sciences Corporation, a high technology supplier of systems and sensors for homeland security and defense markets, announced today that it will exhibit its QS-B220 desktop explosives and drugs trace detectors at Air Cargo Americas on November 6th through 8th in Miami, Florida at booth #929.

Implant Sciences' QS-B220 has recently been added to the "Qualified" section of the Air Cargo Screening Technology List (ACSTL), joining the list of products from which the TSA encourages regulated customers to purchase. Carriers and freight forwarders now have the option of deploying a screening technology that is free from radioactive materials and emits no ionizing radiation.

Only equipment listed on the ACSTL can be used for screening cargo carried on passenger planes landing or taking off from American airports. Additionally, many other countries accept TSA qualification when making purchase decisions.

"Air Cargo Americas is a great venue for us to highlight our QS-B220. Our system is recognized in the air cargo screening field as the new standard in trace detection," stated Todd Swearingen, General Manager, Americas for Implant Sciences. "A number of prospective buyers have heard from our current users that the QS-B220 is technologically superior to the competition. We look forward to demonstrating the product's competitive advantages to buyers throughout the Americas."

"This is a critical and exciting time for Implant Sciences. The QS-B220 has achieved a string of regulatory successes so far this year, and our systems have built a reputation for being easy-to-use and low-cost to maintain. We believe that an investment in trade shows and exhibitions this fall will help us capitalize on this momentum and increase our market share," stated Implant Sciences' President and CEO, Glenn D. Bolduc.

The 2011, Air Cargo Americas International Congress and Exhibition was the largest air cargo exhibition in the Western Hemisphere, with 6,903 international aviation and maritime business executives from 65 countries visiting the exhibition. According to Air Cargo Americas, at the Air Cargo & Sea Cargo Americas 2011 exhibition, more than $101 million in actual and projected sales were reported by exhibitors.

About the QS-B220 Desktop Explosives Trace Detector

The QS-B220 uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives. With significantly lower maintenance requirements than competing systems, the QS-B220 can be deployed for a much lower total cost of ownership than other approved products. Featuring a radioactive material-free design, push-button maintenance and diagnostics, and a patented inCal™ internal automatic calibration system, the QS-B220 brings new levels of performance and convenience to desktop trace detection users with unsurpassed ease of use.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    L3Harris Technologies, Inc.. (2022, June 22). Implant Sciences’ QS-B220 Desktop Explosives and Drugs Trace Detectors to be Showcased at Air Cargo Americas. AZoSensors. Retrieved on November 22, 2024 from https://www.azosensors.com/news.aspx?newsID=6849.

  • MLA

    L3Harris Technologies, Inc.. "Implant Sciences’ QS-B220 Desktop Explosives and Drugs Trace Detectors to be Showcased at Air Cargo Americas". AZoSensors. 22 November 2024. <https://www.azosensors.com/news.aspx?newsID=6849>.

  • Chicago

    L3Harris Technologies, Inc.. "Implant Sciences’ QS-B220 Desktop Explosives and Drugs Trace Detectors to be Showcased at Air Cargo Americas". AZoSensors. https://www.azosensors.com/news.aspx?newsID=6849. (accessed November 22, 2024).

  • Harvard

    L3Harris Technologies, Inc.. 2022. Implant Sciences’ QS-B220 Desktop Explosives and Drugs Trace Detectors to be Showcased at Air Cargo Americas. AZoSensors, viewed 22 November 2024, https://www.azosensors.com/news.aspx?newsID=6849.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.